Structural mean model; On-demand dosing regimen; medication event monitoring systems (MEMS)
Abstract :
[en] Background
Structural mean models (SMM) can be used to estimate treatment efficacy when drug exposure varies. We applied SMM to evaluate the clinical benefits of a proton pump inhibitor prescribed to be taken as needed to alleviate epigastric pain. We also investigated a new diagnostic approach to evaluate model assumptions.
Methods
All patients were suffering from non-erosive reflux disease or functional ulcer-like dyspepsia and were prescribed a proton pump inhibitor to be taken as needed for relief of epigastric pain. The primary endpoint was a score variable that expresses the magnitude of gastro-intestinal symptoms at 8 weeks after randomization. We developed linear and loglinear versions of the SMM to derive an unbiased estimator of the reduction in symptom score as a function of exposure to the test drug. Semi-parametric models based on splines and corresponding simultaneous confidence bands identified the presence of potential interactions between drug exposure and baseline covariates.
Results
The on-demand dosing regimen generated a wide range of drug exposure. Application of SMM showed that the potential treatment induced reduction in symptom score was much greater than the average treatment reduction observed in this population of patients. Our diagnostic tool was useful for detecting the interaction between drug exposure and baseline covariates.
Limitations
Analysis could only be performed over the two first months after randomization because, afterwards, many patients dropped out from the placebo group.
Conclusions
The structural mean model approach allows one to estimate treatment efficacy in the presence of variable drug exposure. Similar results were obtained using linear and loglinear SMM.
Disciplines :
Physical, chemical, mathematical & earth Sciences: Multidisciplinary, general & others Human health sciences: Multidisciplinary, general & others
Author, co-author :
Comté, Laetitia ; Université de Liège - ULiège > Département de mathématique > Statistique (aspects expérimentaux)
Lee, J., Ellenberg, J., Hirtz, D., Nelson, K., Analysis of clinical trials by treatment actually received: Is it really an option? (1991) Stat Med, 10, pp. 1595-1605
Goetghebeur, E., Pocock, S., Statistical issues in allowing for noncompliance and withdrawal (1993) Drug Inform J, 27, pp. 837-845
Bellamy, S.L., Lin, J.Y., Have, T.R.T., An introduction to causal modelling in clinical trials (2007) Clin Trials, 4, pp. 58-73
Sommer, A., Zeger, S.L., On estimating efficacy from clinical trials (1991) Stat Med, 10, pp. 45-52
Frangakis, C.E., Rubin, D.B., Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes (1999) Biometrika, 86, pp. 365-379
Efron, B., Feldman, D., Compliance as an explanatory variable in clinical trials (1991) J Am Stat Assoc, 86, pp. 9-25. , 7. Robins JM. Correcting for non-compliance in randomized trials using structural nested mean models. Commun Stat Theory Meth 1994
23: 2379-2412
Robins, J.M., Correcting for non-compliance in randomized trials using structural nested mean models (1994) Commun Stat Theory Meth, 23, pp. 2379-2412
Fisher-Lapp, K., Goetghebeur, E., Practical properties of some structural mean analyses of the effect of compliance in randomized trials (1999) Control Clin Trials, 20, pp. 531-546
Robins, J., Rotnitzky, A., Estimation of treatment effects in randomised trials with non-compliance and a dichotomous outcome using structural mean models (2004) Biometrika, 91, pp. 763-783
Vansteelandt, S., Goetghebeur, E., Causal inference with generalized structural mean models (2003) J R Stat Soc B, 65, pp. 817-835
Mark, S.D., Robins, J.M., Estimating the causal effect of smoking cessation in the presence of confounding factors using a rank preserving structural failure time model (1993) Stat Med, 12, pp. 1605-1628
Loeys, T., Goetghebeur, E., A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance (2003) Biometrics, 59, pp. 100-105
Greenland, S., Lanes, S., Jara, M., Estimating effects from randomized trials with discontinuations: The need for intent-to-treat design and G-estimation (2008) Clin Trials, 5, pp. 5-13
Tanaka, S., Matsuyama, Y., Shiraki, M., Ohashi, Y., Estimating the effects of time-varying treatments: Incidence of fractures among postmenopausal Japanese women (2007) Epidemiology, 18, pp. 529-536
Vansteelandt, S., Babanezhad, M., Goetghebeur, E., Correcting instrumental variables estimators for systematic measurement error (2009) Stat Sinica, 19, pp. 1223-1246
Vrijens, B., Tousset, E., Rode, R., Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models (2005) J Clin Pharmacol, 45, pp. 461-467
Harter, J.G., Peck, C.C., Chronobiology. Suggestions for integrating it into drug development (1991) Ann N Y Acad Sci, 618, pp. 563-571
Sheiner, L.B., Learning versus confirming in clinical drug development (1997) Clin Pharmacol Ther, 61, pp. 275-291
Osterberg, L., Blaschke, T., Adherence to medication (2005) N Engl J Med, 353, pp. 487-497
Hernan, M.A., Robins, M., Instruments for causal inference: An epidemiologist's dream? (2006) Epidemiology, 17, pp. 360-372
Vansteelandt, S., Goetghebeur, E., Sense and sensitivity when correcting for observed exposures in randomized clinical trials (2005) Stat Med, 24, pp. 191-210
Newey, W.K., McFadden, D., (1994) Large Sample Estimation and Hypothesis Testing. Handbook of Econometrics, 4. , Elsevier, Amsterdam
Van der Vaart, A.W., (1998) Asymptotic Statistics, , Cambridge University Press, Cambridge
Efron, B., Tibshirani, R.J., (1993) An Introduction to the Bootstrap, , Chapman & Hall, San Francisco
Ruppert, D., Wand, M.P., Carroll, R.J., (2003) Semiparametric Regression, , Cambridge Series in Statistical and Probabilities Mathematics, Cambridge
Chamberlain, G., Asymptotic efficiency in estimation with conditional moment restrictions (1987) J Economet, 34, pp. 305-334
Bickel, P.J., Klaassen, C.A.J., Ritov, Y., Wellner, J.A., (1993) Efficient and Adaptive Estimation for Semiparametric Models, , Springer-Verlag, New York
Goetghebeur, E., Lapp, K., The effect of treatment compliance in a placebo-controlled trial: Regression with unpaired data (1997) Appl Statist, 46, pp. 351-364
